Housing Instability Tied to Higher Risk for Dementia Diagnosis
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Dec. 6, 2023 -- Veterans experiencing housing instability have a substantially higher risk for receiving an Alzheimer disease or related dementia (ADRD) diagnosis versus a matched cohort of stably housed veterans, according to a study published online Dec. 6 in the Journal of the American Geriatrics Society.
Jill S. Roncarati, Sc.D., from the Veterans Affairs Bedford Healthcare System in Massachusetts, and colleagues examined the rate of ADRD diagnosis for veterans experiencing homelessness and housing instability versus a matched cohort of stably housed veterans during a nine-year period (88,388 veterans total).
The researchers found that in the unadjusted model, veterans with housing instability had an increased risk for ADRD (hazard ratio, 1.33) compared with veterans with housing stability. This finding persisted in the adjusted model (hazard ratio, 1.41). By the midpoint of the study in 2015, 7.23 percent of housing-insecure and 3.66 percent of housing-stable veterans had an ADRD diagnosis.
"Veterans experiencing housing instability have a substantially higher risk of receiving an ADRD diagnosis than a matched cohort of stably housed veterans," the authors write. "Health systems and providers should consider cognitive screening among people experiencing housing insecurity. Existing permanent supportive housing programs should consider approaches to modify wraparound services to support veterans experiencing ADRD."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-07 08:15
Read more
- Your Sense of Smell May Be Quicker Than You Think
- Onions in McDonalds' Quarter Pounders Linked to E. Coli Outbreak Have Been Recalled
- Science Reveals Why Cancer Immunotherapies Can Sometimes Harm the Heart
- COVID-19 Burden in Hospitals Affects Risk for In-Hospital Adverse Events
- Clinical Practice Guidelines Updated for Primary Prevention of Stroke
- U.S. Alcohol Intake Rose During Pandemic, and for Years After
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions